Risk of SARS-CoV-2 infection following 3-dose homologous BNT162b2 or mRNA-1273 in patients with inflammatory rheumatic diseases

CE Raptis, C Polysopoulos, CT Berger, A Ciurea, DO Andrey, T Maletic, M Riek, A Scherer, von Loga, J Safford, K Lauper, B Moeller, N Vuilleumier, A Finckh, A Rubbert-Roth

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)11S
Number of pages1
JournalSwiss Medical Weekly
Issue number8 S271
Publication statusPublished - 28 Aug 2023
EventAnnual meeting of the Swiss Society of Rheumatology 2023 - Interlaken, Switzerland
Duration: 31 Aug 20231 Sept 2023

Cite this